慢性失语症短期强化语言-动作治疗的长期稳定性:1-2年随访研究
该研究纳入38例慢性失语症患者,接受每周6-12.5小时、持续2-4周的强化语言-动作治疗(ILAT),并在治疗后8-30个月复评。标准化失语症测验显示ILAT带来的改善可维持长达2.5年,相对年轻患者(<60岁)的改善保留更好;交际效能指标在强化治疗期间有改善,但长期稳定性不一致。
要点
- ILAT短期强化治疗后的语言功能改善可维持至治疗后2.5年。
- 相对年轻患者(<60岁)的疗效长期保留更好。
- 交际效能指标的长期稳定性不一致。
核心结论
- ILAT强化言语-语言治疗带来的获益在治疗结束后可维持长达2.5年。
研究设计与样本
- 38例慢性失语症患者接受ILAT,每周6-12.5小时、持续2-4周,并在治疗后8-30个月复评。
主要发现
- 标准化临床失语症测验(Aachen Aphasia Test)显示ILAT带来显著改善并维持至2.5年。
- 相对年轻患者(<60岁)的改善保留相对更好。
- 交际效能指标在强化治疗期间有改善,但长期稳定性不一致。
临床怎么用
- 临床可考虑将慢性失语症治疗从稀疏模式转向强化ILAT模式,以争取长期维持疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background. Intensive aphasia therapy can improve language functions in chronic aphasia over a short therapy interval of 2-4 weeks. For one intensive method, intensive language-action therapy, beneficial effects are well documented by a range of randomized controlled trials. However, it is unclear to date whether therapy-related improvements are maintained over years. Objective. The current study aimed at investigating long-term stability of ILAT treatment effects over circa 1-2 years (8-30 months). Methods. 38 patients with chronic aphasia participated in ILAT and were re-assessed at a follow-up assessment 8-30 months after treatment, which had been delivered 6-12.5 hours per week for 2-4 weeks. Results. A standardized clinical aphasia battery, the Aachen Aphasia Test, revealed significant improvements with ILAT that were maintained for up to 2.5 years. Improvements were relatively better preserved in comparatively young patients (<60 years). Measures of communicative efficacy confirmed improvements during intensive therapy but showed inconsistent long-term stability effects. Conclusions. The present data indicate that gains resulting from intensive speech-language therapy with ILAT are maintained up to 2.5 years after the end of treatment. We discuss this novel finding in light of a possible move from sparse to intensive therapy regimes in clinical practice.
引用
- Doppelbauer L, Mohr B, Dreyer FR, et al. Long-Term Stability of Short-Term Intensive Language-Action Therapy in Chronic Aphasia: A 1-2 year Follow-Up Study. Neurorehabil Neural Repair. 2021. PMID: 34232091. doi:10.1177/15459683211029235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。